Bullous pemphigoidbullous pemphigoid, bullous pemphigoid pictures
Bullous pemphigoid is an acute or chronic autoimmune skin disease, involving the formation of blisters, more appropriately known as bullae, at the space between the epidermis and dermis skin layers It is classified as a type II hypersensitivity reaction, with the formation of anti-hemidesmosome antibodies
- 1 Signs and symptoms
- 2 Causes
- 3 Pathophysiology
- 4 Diagnosis
- 5 Treatment
- 6 Prognosis
- 7 Epidemiology
- 8 Research
- 9 See also
- 10 References
- 11 Further reading
- 12 External links
Signs and symptomsedit
Clinically, the earliest lesions may appear urticarial like hives Tense bullae eventually erupt, most commonly at the inner thighs and upper arms, but the trunk and extremities are frequently both involved Any part of the skin surface can be involved Oral lesions are present in a minority of cases1 The disease may be acute, but typically will wax and wane Several other skin diseases may have similar symptoms However, milia are more common with epidermolysis bullosa acquisita, because of the deeper antigenic targets A more ring-like configuration, with a central depression or centrally collapsed bullae may indicate linear IgA disease Nikolsky's sign is negative unlike pemphigus vulgaris where it is positive
In most cases of bullous pemphigoid, no clear precipitating factors are identified1 Potential precipitating events that have been reported include exposure to ultraviolet light and radiation therapy12 Onset of bullous pemphigoid has also been associated with certain drugs, including furosemide, and other nonsteroidal anti-inflammatory agents, captopril, penicillamine, and antibiotics2
The bullae are formed by an immune reaction, initiated by the formation of IgG3 autoantibodies targeting Dystonin, also called Bullous Pemphigoid Antigen 1,4 and/or type XVII collagen, also called Bullous Pemphigoid Antigen 2,5 which is a component of hemidesmosomes A different form of dystonin is associated with neuropathy4 Following antibody targeting, a cascade of immunomodulators results in a variable surge of immune cells, including neutrophils, lymphocytes and eosinophils coming to the affected area Unclear events subsequently result in a separation along the dermoepidermal junction and eventually stretch bullae
Diagnosis is based on two biopsies of the skin, one submitted for routine H&E staining and one for immunofluorescence studies
Treatments include class I topical steroids clobetasol, halobetasol, etc which in some studies have proven to be equally effective as systemic, or pill, therapy and somewhat safer1 However, in difficult-to-manage or widespread cases, systemic prednisone and powerful steroid-free immunosuppressant medications, such as methotrexate, azathioprine or mycophenolate mofetil, may be appropriate16 Antibiotics such as tetracycline or erythromycin may also control the disease, particularly in patients who cannot use corticosteroids6 The anti-CD20 monoclonal antibody rituximab has been found to be effective in treating some otherwise refractory cases of bullous pemphigoidcitation needed
IgA-mediated pemphigoid can often be difficult to treat even with usually effective medications such as rituximab7
Bullous pemphigoid may be self-resolving in a period ranging from several months to many years even without treatment1 Poor general health related to old age is associated with a poorer prognosis1
Very rarely seen in children, bullous pemphigoid most commonly occurs in people 70 years of age and older1 Estimated frequency is seven to 14 cases per million per year, but has been reported to be as high as 472 cases per million per year in Scottish men older than 851 At least one study indicates the incidence might be increasing in the United Kingdom8 Some sources report it affects men twice as frequently as women,6 while others report no difference between the sexes1
Many mammals can be afflicted, including dogs, cats, pigs, and horses, as well as humans It is very rare in dogs; on average, three cases are diagnosed around the world each yearcitation needed
Animal models of bullous pemphigoid have been developed using transgenic techniques to produce mice lacking the genes for the two known autoantigens, dystonin and collagen XVII45
- Cicatricial pemphigoid
- Gestational pemphigoid
- List of target antigens in pemphigoid
- List of immunofluorescence findings for autoimmune bullous conditions
- ^ a b c d e f g h i j Wolff K, Goldsmith L, Gilchrest B, Stephen Katz, Amy Paller, David Leffell 17 October 2007 "Chapter 54 Bullous Pemphigoid" In Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ Fitzpatrick's Dermatology In General Medicine, Two Volumes 7th ed Mcgraw-hill ISBN 978-0-07-146690-5 Retrieved July 21, 2012
- ^ a b Lawrence S Chan 2011 "Bullous Pemphigoid" eMedicine Reference
- ^ "Dorlands Medical Dictionary:bullous pemphigoid" Retrieved 2010-06-24
- ^ a b c "OMIM Entry - 113810 - DYSTONIN; DST" permanent dead link
- ^ a b "OMIM Entry - 113811 - COLLAGEN, TYPE XVII, ALPHA-1; COL17A1" permanent dead link
- ^ a b c ""Bullous Pemphigoid" Quick Answers to Medical Diagnosis and Therapy" Retrieved 2012-07-21
- ^ He Y, Shimoda M, Ono Y, Villalobos IB, Mitra A, Konia T, Grando SA, Zone JJ, Maverakis E 2015 "Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab" JAMA Dermatol 151 6: 646–50 PMID 25901938 doi:101001/jamadermatol201559
- ^ Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J 2008 "Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study" BMJ 337: a180 PMC 2483869 PMID 18614511 doi:101136/bmja180
- Wojnarowska, F; Kirtschig, G; Highet, AS; Venning, VA; Khumalo, NP; British Association of, Dermatologists Aug 2002 "Guidelines for the management of bullous pemphigoid" The British journal of dermatology 147 2: 214–21 PMID 12174090 doi:101046/j1365-2133200204835x
- "Bullous Pemphigoid" PDF badorguk Archived from the original PDF on 6 October 2010
- Bullous pemphigoid on American Osteopathic College of Dermatology
- DermNet immune/pemphigoid
- Bullous pemphigoid on Penn State College of Medicine
- Skin antibodies pemphigoid- look under the heading "Other diseases"
|see also fibrous proteins|
bullous pemphigoid, bullous pemphigoid autoimmune disease, bullous pemphigoid histology, bullous pemphigoid icd 10, bullous pemphigoid in dogs, bullous pemphigoid pictures, bullous pemphigoid skin disease, bullous pemphigoid symptoms, bullous pemphigoid treatment, bullous pemphigoid vs pemphigus vulgaris
Bullous pemphigoid Information about
Bullous pemphigoid viewing the topic.
There are excerpts from wikipedia on this article and video
Our site has a system which serves search engine function.
You can search all data in our system with above button which written "What did you look for? "
Welcome to our simple, stylish and fast search engine system.
We have prepared this method why you can reach most accurate and most up to date knowladge. The search engine that developed for you transmits you to the latest and exact information with its basic and quick system.
You can find nearly everything data which found from internet with this system.